Damon L Bass
3PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 16, 2022
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years.Fengchun Zhang, Jie Zheng, Yang Li
|Sep 17, 2021
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison.Hermine I Brunner, Carlos Abud-Mendoza, Masaaki Mori
|Jul 03, 2021
Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea.Yoshiya Tanaka, Sang-Cheol Bae, Damon Bass
Pageof 1
Frequent Collaborators
3 joint publications
David A Roth
2 joint publications
Myron Chu
2 joint publications
Kathleen DeRose
2 joint publications
Beulah N Ji
2 joint publications
Regina Kurrasch
2 joint publications
Jenny Lowe
2 joint publications
Paige Meizlik
2 joint publications
Fengchun Zhang
1 joint publications
Yoshiya Tanaka
1 joint publications
Sang-Cheol Bae
